Remove Due Diligence Remove Globalization Remove Market Intelligence Remove Pharmaceutical
article thumbnail

5 ESG Investing Trends and Developments to Watch in 2023

Alpha Sense BI

But today, ESG has emerged as a business-as-usual topic, even amid uncertain global economic conditions. The Drivers Behind Change in ESG Investing The intentions behind ESG investing are altruistic: to influence the mainstream finance industry into funneling private capital to address global challenges.

Finance 98
article thumbnail

AI in Biopharma: Use Cases and Considerations

Alpha Sense BI

Massive Data Analysis It’s clear that the pharmaceutical industry is increasingly in need of handling and interpreting expansive datasets efficiently and accurately. In the realm of supplier relations, AI applications provide transparency and foster collaboration between pharmaceutical companies and their partners.

article thumbnail

M&A in Healthcare: 2024 Outlook

Alpha Sense BI

According to PwC’s Annual Global CEO survey, 54% of healthcare industry CEOs intend to make at least one acquisition in the next three years. This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI.